885 related articles for article (PubMed ID: 17663991)
21. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
22. Cell-mediated cytotoxicity evaluation using monoclonal antibody staining for target or effector cells with annexinV/propidium iodide colabeling by fluorosphere-adjusted counts on three-color flow cytometry.
Ozdemir O; Ravindranath Y; Savaşan S
Cytometry A; 2003 Nov; 56(1):53-60. PubMed ID: 14566939
[TBL] [Abstract][Full Text] [Related]
23. A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: comparisons to a 4 h 51Cr-release assay.
Kim GG; Donnenberg VS; Donnenberg AD; Gooding W; Whiteside TL
J Immunol Methods; 2007 Aug; 325(1-2):51-66. PubMed ID: 17617419
[TBL] [Abstract][Full Text] [Related]
24. Stable expression of EBV-gp350 on the surface of NC37 cells confers natural killer (NK)-cell susceptibility or resistance, depending on the assay used to assess NK-mediated function.
Sumonwiriya M; Horhthongkham N; Pattanapanyasat K; Ampol S; Sutthent R; Kantakamalakul W
J Virol Methods; 2009 Oct; 161(1):154-60. PubMed ID: 19539652
[TBL] [Abstract][Full Text] [Related]
25. Flow cytometric analysis of natural killer cell function as a clinical assay.
Hatam L; Schuval S; Bonagura VR
Cytometry; 1994 May; 16(1):59-68. PubMed ID: 8033735
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of cytotoxic cell-target cell conjugates. Comparison between flow cytometric analysis and 51Cr binding assay.
Heltai S; Poggi A; Sabbadini MG; Zocchi MR
Haematologica; 1990; 75(2):191-3. PubMed ID: 2358208
[TBL] [Abstract][Full Text] [Related]
27. A cytotoxic NK-cell line (NK-92) for ex vivo purging of leukemia from blood.
Klingemann HG; Wong E; Maki G
Biol Blood Marrow Transplant; 1996 May; 2(2):68-75. PubMed ID: 9118301
[TBL] [Abstract][Full Text] [Related]
28. [Cytotoxicity of allogenetic natural killer cells against CD34+ acute myelogenous leukemia cells].
Niu XQ; Guo KY; Zhou J; Hu LS; Tu SF; She MR
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb; 28(2):173-5. PubMed ID: 18250035
[TBL] [Abstract][Full Text] [Related]
29. Calcein-acetyoxymethyl cytotoxicity assay: standardization of a method allowing additional analyses on recovered effector cells and supernatants.
Neri S; Mariani E; Meneghetti A; Cattini L; Facchini A
Clin Diagn Lab Immunol; 2001 Nov; 8(6):1131-5. PubMed ID: 11687452
[TBL] [Abstract][Full Text] [Related]
30. Effect of cyclosporin A on interleukin-15-activated umbilical cord blood natural killer cell function.
Lin SJ; Kuo ML
Cytotherapy; 2008; 10(4):397-405. PubMed ID: 18574772
[TBL] [Abstract][Full Text] [Related]
31. Ex vivo expansion of highly purified NK cells for immunotherapy after haploidentical stem cell transplantation in children.
Koehl U; Esser R; Zimmermann S; Tonn T; Kotchetkov R; Bartling T; Sörensen J; Grüttner HP; Bader P; Seifried E; Martin H; Lang P; Passweg JR; Klingebiel T; Schwabe D
Klin Padiatr; 2005; 217(6):345-50. PubMed ID: 16307421
[TBL] [Abstract][Full Text] [Related]
32. [Morphological observation on NK/LAK cell-mediated lysis of human oral carcinoma cells].
Zheng YJ; Zhang J; Wang SM; Zhang JR
Di Yi Jun Yi Da Xue Xue Bao; 2004 Apr; 24(4):392-6. PubMed ID: 15090306
[TBL] [Abstract][Full Text] [Related]
33. Effect of altered membrane fluidity on NK cell-mediated cytotoxicity. I. Selective inhibition of the recognition or post recognition events in the cytolytic pathway of NK cells.
Roozemond RC; Bonavida B
J Immunol; 1985 Apr; 134(4):2209-14. PubMed ID: 3855929
[TBL] [Abstract][Full Text] [Related]
34. Measuring human mast cell-mediated cytotoxicity against human tumour cells: three-colour flow cytometry using monoclonal antibody target staining with annexin V / propidium iodide co-labelling of death.
Ozdemir O
Allergol Immunopathol (Madr); 2011; 39(5):259-66. PubMed ID: 21236549
[TBL] [Abstract][Full Text] [Related]
35. Comparative study of four fluorescent probes for evaluation of natural killer cell cytotoxicity assays.
Cholujová D; Jakubíková J; Kubes M; Arendacká B; Sapák M; Ihnatko R; Sedlák J
Immunobiology; 2008; 213(8):629-40. PubMed ID: 18765168
[TBL] [Abstract][Full Text] [Related]
36. Magnetically labeled human natural killer cells, accumulated in vitro by an external magnetic force, are effective against HOS osteosarcoma cells.
Nakashima Y; Deie M; Yanada S; Sharman P; Ochi M
Int J Oncol; 2005 Oct; 27(4):965-71. PubMed ID: 16142312
[TBL] [Abstract][Full Text] [Related]
37. Studies on the mechanism of natural killer cytotoxicity. II. coculture of human PBL with NK-sensitive or resistant cell lines stimulates release of natural killer cytotoxic factors (NKCF) selectively cytotoxic to NK-sensitive target cells.
Wright SC; Weitzen ML; Kahle R; Granger GA; Bonavida B
J Immunol; 1983 May; 130(5):2479-83. PubMed ID: 6833762
[TBL] [Abstract][Full Text] [Related]
38. Cytolytic activity of human natural killer cell subpopulations isolated by four-color immunofluorescence flow cytometric cell sorting.
Srour EF; Leemhuis T; Jenski L; Redmond R; Jansen J
Cytometry; 1990; 11(3):442-6. PubMed ID: 2187659
[TBL] [Abstract][Full Text] [Related]
39. Combination immunotherapy with clinical-scale enriched human gammadelta T cells, hu14.18 antibody, and the immunocytokine Fc-IL7 in disseminated neuroblastoma.
Otto M; Barfield RC; Martin WJ; Iyengar R; Leung W; Leimig T; Chaleff S; Gillies SD; Handgretinger R
Clin Cancer Res; 2005 Dec; 11(23):8486-91. PubMed ID: 16322312
[TBL] [Abstract][Full Text] [Related]
40. Rapid, flow cytometric assay for NK alloreactivity reveals exceptions to rules governing alloreactivity.
De Santis D; Foley BA; John E; Senitzer D; Christiansen FT; Witt CS
Biol Blood Marrow Transplant; 2010 Feb; 16(2):179-91. PubMed ID: 19879950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
